Status:

UNKNOWN

Pharmacist-led Hepatitis C Management

Lead Sponsor:

University Health Network, Toronto

Conditions:

Hepatitis C Virus Infection

Eligibility:

All Genders

18-80 years

Phase:

PHASE4

Brief Summary

Hepatitis C virus (HCV) continues to disproportionately affect vulnerable and marginalized persons in Canada. During the interferon treatment era, certain circumstances precluded individuals from rece...

Eligibility Criteria

Inclusion

  • HCV infection
  • HCV RNA \> 1,000 IU/mL
  • Aged 18 to 80
  • Willingness and capacity to provide informed consent

Exclusion

  • Presence of or history of decompensated cirrhosis. This will be defined as evidence of clinical decompensation (history of either ascites, variceal hemorrhage, or hepatic encephalopathy/confusion), and Child-Pugh-Turcotte and Model for Endstage Liver Disease (MELD) score will also be used to assess this using laboratory investigations and clinical findings.
  • Platelets \< 75,000/mm3, total albumin \<35 g/L, total bilirubin (total and direct) \>34.2 μmol/L, International Normalized Ratio (INR) \>1.5
  • History of current or past hepatocellular carcinoma
  • Hepatitis B virus (HBV) co-infection as indicated by positive testing for hepatitis B surface antigen (HBsAg +ve)or untreated HIV co-infection
  • Prior HCV antiviral therapy with direct-acting antivirals with or without peginterferon/ribavirin
  • Chronic liver disease other than mild non-alcoholic or alcoholic fatty liver disease from a cause other than HCV
  • Significant co-morbid illness that precludes inclusion in the opinion of the investigator
  • Life expectancy of less than 1 year. If clarity is required, the provider who delivered the diagnosis will be contacted.
  • Pregnancy/breast-feeding/inability to use contraception
  • Use of concomitant contraindicated drugs

Key Trial Info

Start Date :

April 13 2022

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 1 2023

Estimated Enrollment :

108 Patients enrolled

Trial Details

Trial ID

NCT04322981

Start Date

April 13 2022

End Date

December 1 2023

Last Update

April 27 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Specialty Rx Solutions

Toronto, Ontario, Canada, M4Y 1G7